Features
The Past and Future of Trabeculectomy
New scarring prophylaxis could facilitate greater use of the most effective glaucoma procedure.
By Keith Barton, MD
Cost-benefit Analysis of Virtual Reality Visual Fields as Adjunct to Standard Automated Perimetry
Headsets can be both cost effective and convenient.
By Sean J. McCafferty, MD
New Supraciliary Interventions for Glaucoma
Increased attention is being given to this anatomic space for glaucoma procedures.
By Ticiana De Francesco, MD, Sean Ianchulev, MD, MPH
Floppy Eyelid Syndrome and Obstructive Sleep Apnea in Glaucoma
Screen for a common glaucoma risk factor with this one weird trick.
By Matthew J.A. Brink, MD, Jack Martinyan, BS
Web Exclusives
Interventional Glaucoma Q&A With Sahar Bedrood, MD
By Sahar Bedrood, MD, PhD
Departments
From the Editor: Local Coverage Determination Debacle Part Two
By Nathan M. Radcliffe, MD
Trials in Focus: The COAST Trial of Selective Laser Trabeculoplasty
Researchers are looking at the best way to perform primary and repeat SLT.
By Tony Realini, MD, MPH
Coding: Stents and Visual Field Testing
Reimbursement for glaucoma surgery with an aqueous drainage device often depends on visual field testing.
By Kevin J. Corcoran, COE, CPC, CPMA, FNAO
Patients Are Asking: Why Is My Glaucoma Getting Worse When My Eye Pressures Are so Good?
Help patients optimize systemic factors in normal-tension glaucoma.
By Victoria M. Addis, MD
Product Spotlight: A New Lens Makes Two-handed MIGS Possible
Gonio Ready expands options for minimally invasive surgery.
By Karen Appold, contributing writer
News
ViaLase Completes Enrollment for Pivotal Trial of Laser for POAG
By Jennifer Ford, senior managing editor
Miniject Safe and Effective at 3 Years
By Conni Koury, contributing editor
Cilioscleral Device Significantly and Safely Reduced IOP at 1 Year
By Conni Koury, contributing editor
Fixed High-energy SLT Superior to Standard Titrated Protocol for IOP Lowering
By Conni Koury, contributing editor
Netarsudil Plus Latanoprost Noninferior to Bimatoprost-timolol Combo
By Conni Koury, contributing editor
Data From Large-scale Investigation Demonstrate MIGS Efficacy
By Conni Koury, contributing editor
Intravitreal Implant Moves to Phase 2a
By Conni Koury, contributing editor
Generic Brimonidine 0.1% Launched
By Conni Koury, contributing editor
First In-human Study of Titratable Aqueous Shunt Therapy Has Begun
By Conni Koury, contributing editor
Telemedicine Screenings Effective, Scalable for At-risk Patients
By Conni Koury, contributing editor
FDA Clears Belkin Eagle Device for SLT
By Conni Koury, contributing editor
Glaukos iDose TR Gets FDA Approval
By Conni Koury, contributing editor
Restrictive LCDs for MIGS Will Not Go Into Effect
Five MACs retired their proposed LCDs for MIGS.